Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion
Open Access
- 1 August 2003
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 126 (2), 482-489
- https://doi.org/10.1016/s0022-5223(03)00699-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Pravastatin Attenuates Lower Torso Ischaemia–Reperfusion-induced Lung Injury by Upregulating Constitutive Endothelial Nitric Oxide SynthaseEuropean Journal of Vascular and Endovascular Surgery, 2001
- Direct Vascular Effects of HMG-CoA Reductase InhibitorsTrends in Cardiovascular Medicine, 2000
- Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide SynthaseJournal of Biological Chemistry, 1997
- Bacterial toxins that target Rho proteins.Journal of Clinical Investigation, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Molecular characterization of endothelin receptorsTrends in Pharmacological Sciences, 1992
- Regulation of the mevalonate pathwayNature, 1990